Clinical Trial Partnerships in Oncology
 Assessing the Landscape of Clinical Trial Design, Planning and Execution for Cancer Therapies

May 19, 2021 | Live Virtual Forum (EST)

Media Center

Fast Track your Attendance

Digital Sponsorship Opportunities

In a time where the possibility for face-to-face interaction is limited, Unite Life Sciences understands it’s more important than ever to help you engage qualified decision makers and generate fresh new leads.

Partner with Rethinking Clinical Trials in Oncology, virtual summit, October 28.

Offer content without having to leave your home to raise your profile and reinforce your thought leadership status – all while generating highly qualified leads!

Download the digital sponsorship opportunities brochure to see how to get involved. To have a copy sent to your inbox, or to discuss sponsorship opportunities, email us at enquiry@unitelifesciences.com.

Past Attendee Snapshot

Download the Past Attendee Snapshot for Rethinking Clinical Trials in Oncology to give you an idea of which companies and industry executives you can expect to meet and network with this spring through our live, virtual, interactive forum.

For questions or details pertaining to sponsorship/exhibition, contact us at enquiry@unitelifesciences.com

Event details: May 19, 2021 | Virtual Forum 

Whitepapers, Reports, & Expert Insights

Designing Trials in the Age of Rapidly Developing Innovation

In the fall of 2020, Unite Life Sciences brought together the below experts to address some of the industry's most pressing questions around designing clinical trials. We have adaptive design, but what else can be considered in diverse approaches to treat cancer? What have we learned about what else might be considered to augment with real world evidence and other data sets that could be valuable to understand the safety and effectiveness of a new molecule? How can industry be “better” at designing trials to utilize resources in the best way possible?

Speakers:

  • Michel Azoulay MD - Clinical Development Strategy, Sanofi
  • Caroline Germa - Vice President, Head Clinical Development, Early Portfolio, Oncology R&D, AstraZeneca
  • David S. Hong MD - Associate Vice President of Clinical Research, M.D. Anderson Cancer Center
  • Kenneth G. Faulkner PhD - Vice President of eCOA Scientific Services, ERT

Fill out the form to start watching one of our most dynamic sessions from October's virtual forum, Rethinking Clinical Trials in Oncology, and be sure to RSVP for the spring 2021 forum.